retatrutide safety What are the considerations for using retatrutide? retatrutide safety profile clinical trials

Specifically, rodent studies showed an increased incidence of thyroid C-cell tumours (medullary thyroid carcinoma) when exposed to GLP-1 receptor agonists at doses significantly higher than those used therapeutically in humans

This content is for informational purposes only and is not a substitute for professional medical advice

GLP-1 Increases Preovulatory LH Source and the Number of Mature Follicles, as Well as Synchronizing the Onset of Puberty in Female Rats

GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases

The FDA has not identified colorectal cancer as a confirmed risk for this medication class

Bitter Melon contains compounds which can mimic insulin and may stimulate GLP-1 release